Manuel Johanns

6PUBLICATIONS
24CO-AUTHORS
Molecular targetsHaematological tumoursNeurology and neuromuscular diseasesCardiology (incl. cardiovascular diseases)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 21, 2026
The circadian clock controls hepatic stellate cell activation via a BMAL1/CK1ε/REV-ERBα/transgelin signaling pathway.

|Mar 17, 2025
Lactate dehydrogenase A-coupled NAD+ regeneration is critical for acute myeloid leukemia cell survival.

Ayşegül Erdem, Séléna Kaye, Francesco Caligiore

|Oct 24, 2023
The Molecular Circadian Clock Is a Target of Anti-cancer Translation Inhibitors.

Alexandre Berthier, Céline Gheeraert, Manuel Johanns

|Jun 22, 2023
Specific post-translational modifications of soluble tau protein distinguishes Alzheimer's disease and primary tauopathies.

Nathalie Kyalu Ngoie Zola, Clémence Balty, Sébastien Pyr Dit Ruys

|May 27, 2023
Comparison of Different Ex-Vivo Preservation Strategies on Cardiac Metabolism in an Animal Model of Donation after Circulatory Death.

Stefano Mastrobuoni, Manuel Johanns, Martial Vergauwen

|Jan 13, 2023
AMPK inhibits liver gluconeogenesis: fact or fiction?

Manuel Johanns, Louis Hue, Mark H Rider

Pageof 1

Frequent Collaborators

2 joint publications

Gaëtan Herinckx

2 joint publications

Didier Vertommen

2 joint publications

Alexandre Berthier

1 joint publications

Mark H Rider